Breathable Foundation Helps Skin Heal Faster

Barry

Barry Knapp – Oxygenetix Founder

For aesthetic physicians one of the most difficult obstacles to overcome is the downtime associated with a cosmetic procedure. Many female patients are afraid of being seen in public after undergoing an elective cosmetic treatment, or missing time from work. Barry Knapp, Founder and CEO of Oxygenetix Breathable Foundation, a breakthrough medical grade foundation make-up that covers, heals and helps minimalize surgical scars, found the solution to this problem by developing a make-up foundation that completely conceals any obvious signs of a RG treatment, chemical or laser peel, or surgical procedure, and allows the skin to breathe thereby enhancing healing time.

“The skin needs air and water,” said Knapp. “Most skin care products, especially foundation make-up, create an occlusive barrier between the skin and the air causing the skin to go into an open active rebellion.”

According to Knapp, Oxygentix contains a specific product he developed and patented called Ceravitae. This supercharged oxygenating complex formulation proliferates collagen cell connective tissue growth in aging or wounded skin.

Knapp began his career as a young make-up artist in Hollywood where the sight of a  pimple was enough to make any young starlet burst into tears. However, using topical makeup to hide that pimple could create havoc on sensitive skin. Knapp knew he had to either find, or develop, a make-up line that could conceal even the worst acne blemishes and skin problems, without looking false or causing further skin irritation. After much travel and research working alongside a chemist, Knapp developed new products and took several of these ingredients to create a chemically breathable matrix that was tested by world renowned skin product compounding expert, Dr. Peter Pugliese. Dr. Pugliese performed a breathability test proving that the formula worked at 85% air permeability. Today Oxygenetix Breathable Foundation can be found in over 1500 physicians’ offices in North America, as well as 16 countries worldwide. It is developed at the Oxygenetix, FDA cleared laboratory in Los Angeles, CA. www.oxygenetix.com.